Trademarkia Logo

Canada

C$
Trademark Search in Canada
SURFACE ONCOLOGY LOGO IN COLOR
SURFACE ONCOLOGY LOGO IN COLOR
ABANDONED SECTION 36

on 4 May 2021

TM5 Status

DEAD/APPLICATION/ Withdrawn/Abandoned

Your application has been withdrawn or abandoned. You cannot use the TM5 mark.

Last Applicant/ Owned by

SURFACE ONCOLOGY INC.

50 Hampshire StreetCambridge, MA 02139

US

Serial Number

1902922 filed on 6th Jun 2018

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

SURFACE ONCOLOGY LOGO IN COLOR

Trademark usage description

biochemicals, namely, monoclonal antibodies for use in the treatment of cancer biological preparations for the treatment of cancer

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

29 . 1 . 4

BlueBleu

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Classification Information


Class [001]
Biochemicals, namely, monoclonal antibodies for use in the treatment of cancer


Classification kind code

11

Class [005]
Biological preparations for the treatment of cancer


Classification kind code

11

Mark Details


Serial Number

1902922

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 4th May 2021
Abandoned - Section 36
Submitted for opposition 14
on 16th Feb 2021
Default Notice Sent
Submitted for opposition 48
on 8th Jul 2020
Agent Changed
Submitted for opposition 22
on 24th Apr 2020
Search Recorded
Submitted for opposition 20
on 24th Apr 2020
Examiner's First Report
Submitted for opposition 31
on 8th Jun 2018
Formalized
Submitted for opposition 1
on 7th Jun 2018
Created
Submitted for opposition 30
on 6th Jun 2018
Filed